LBF20207PG29: Difference between revisions
m LBF20307PG13 moved to LBF20207PG29 |
No edit summary |
||
| Line 5: | Line 5: | ||
|LipidMaps=LMFA03010024 | |LipidMaps=LMFA03010024 | ||
|SysName=9-oxo-11alpha,15S,19R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |SysName=9-oxo-11alpha,15S,19R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | ||
|Common Name=&&19 (R) -hydroxy Prostaglandin | |Common Name=&&19 (R) -hydroxy Prostaglandin E_2&& | ||
}} | }} | ||
Revision as of 16:30, 19 December 2008
| IDs and Links | |
|---|---|
| LipidBank | XPR1713 |
| LipidMaps | LMFA03010024 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG29 |
| 19 (R) -hydroxy Prostaglandin E2 | |
|---|---|
| |
| Structural Information | |
| 9-oxo-11α,15S,19R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |
| |
| Formula | C20H32O6 |
| Exact Mass | 368.219888756 |
| Average Mass | 368.46448 |
| SMILES | [C@H]([C@@H](C=C[C@H](O)CCC[C@@H](C)O)1)(C(C[C@H]1O)=O)CC=CCCCC(O)=O |
| Physicochemical Information | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
